Helix

OverviewSuggest Edit

Helix is a company focused on personal genomics. It provides comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Additionally, Helix offers a suite of DNA-powered products.

TypePrivate
Founded2015
HQSan Mateo, CA, USMap
Websitehelix.com
Employee Ratings4.3More
Overall CultureCMore
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Sept 2021)239
Revenue (FY, 2018)$10 M(+67%)
Cybersecurity ratingBMore

Key People/Management at Helix

James Lu

James Lu

Chief Executive Officer & Co-Founder
Marc Laurent

Marc Laurent

VP, Partnerships and Operations
Kirsten Mouritsen

Kirsten Mouritsen

Director, Product Management
Sarah Bobulsky

Sarah Bobulsky

VP, Commercial
Elissa Levin

Elissa Levin

VP, Clinical & Policy
Will Lee

Will Lee

VP, Science
Show more

Helix Office Locations

Helix has offices in San Mateo and San Diego
San Mateo, CA, US (HQ)
101 S Ellsworth Ave
San Diego, CA, US
9875 Towne Centre Dr
Show all (2)

Helix Financials and Metrics

Summary Metrics

Founding Date

2015

Helix total Funding

$383 m

Helix latest funding size

$50 m

Time since last funding

4 months ago

Helix investors

Kleiner Perkins, DFJ Growth, Sutter Hill Ventures, Temasek Holdings, LaunchCapital, Warburg Pincus, National Institutes of Health, Illumina, Mayo Clinic, Temasek, Mayo Clinic Ventures, Kleiner Perkins Caufield Byers
Helix's latest funding round in June 2021 was reported to be $50 m. In total, Helix has raised $383 m
Show all financial metrics

Helix Revenue

Helix's revenue was reported to be $10 m in FY, 2018 which is a 66.7% increase from the previous period.
USD

Revenue (Q1, 2019)

1.0m

EBIT (Q1, 2019)

(18.0m)
Annual
USDFY, 2017FY, 2018

Revenue

6.0m10.0m

Revenue growth, %

67%

Depreciation and amortization

6.0m

EBIT

(90.0m)
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

1.0m2.0m1.0m3.0m3.0m2.0m1.0m

EBIT

(16.0m)(22.0m)(21.0m)(20.0m)(23.0m)(18.0m)

EBIT margin, %

(800%)(2200%)(700%)(667%)(1150%)(1800%)
show all
Annual
USDFY, 2017FY, 2018

Total Assets

45.0m154.0m
Quarterly
USDQ2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Total Assets

37.0m59.0m155.0m199.0m177.0m134.0m
show all
Show all financial metrics

Helix Operating Metrics

Mar, 2018Feb, 2020

DNA Tests

11

Products

35
Show all operating metrics

Helix Acquisitions / Subsidiaries

Company NameDateDeal Size
HumanCodeJune 28, 2018

Helix Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

Learn more about our premium products
SecurityScorecard logo

Helix Online and Social Media Presence

Helix's Trends

Embed Graph

Helix Company Culture

  • Overall Culture

    C

    72/100

  • CEO Rating

    B

    76/100

  • Compensation

    D

    53/100

Learn more on Comparably

Helix Blogs

May 04, 2021

Evidence of “double mutant” substitutions E484Q and L452R in the B.1.429 lineage suggest convergent evolution of immune escape mutations

Two variants have been shown to help the SARS-CoV-2 virus avoid the immune system’s antibody response; their emergence in separate viral lineages suggests convergent evolution in response to selective pressure. The post Evidence of “double mutant” substitutions E484Q and L452R in the B.1.429 lineage…
January 06, 2021

Helix, Illumina launch surveillance program as the B.1.1.7 variant of SARS-CoV-2, first identified in the UK, spreads further into the US

Most recent update: January 6th, 2021 What’s new? 47 new cases of B.1.1.7 have been identified, spread across 4 of the 5 states in which we have the statistical power to detect it B.1.1.7 reaffirmed as only a subset of S gene target failure (SGTF) samples B.1.1.7 appears to currently represent 32% o…
January 01, 2021

SARS-CoV-2 UK variant (B.1.1.7) in the US: Four cases identified in Florida and California

The SARS-CoV-2 UK variant (B.1.1.7) strain has recently emerged as the dominant strain in the UK and has been found to be more infectious. Studies from France and the UK have shown that S gene dropout predicts the B.1.1.7 strain with near-perfect accuracy. Last week, we reported observing ~0.5% of r…
December 23, 2020

Is the new SARS-CoV-2 UK variant (B.1.1.7) already in the US? Maybe.

Since the onset of the COVID-19 pandemic, there has been concern about novel SARS-CoV-2 mutations emerging that are more transmissible. Recently, multiple novel strains of SARS-CoV-2 have been found to share the same deletion of amino acids H69 and V70.  At least some of these strains are hypothesiz…
December 17, 2020

5 ways Helix’s research community has advanced science in 2020

As we wrap up 2020 and look back at the year we’ve all endured, it’s important to highlight the places where humanity shone through the darkness. One such place is in our research community.  While the people around the nation were forced into isolation by stay at home orders or self-imposed quarant…
May 27, 2020

What did we learn from >10,000 COVID-19 survey responses?

Our team of researchers are currently working through the data, but we have already found some interesting insights in our collection of survey responses, and we’ve contributed our findings to a worldwide research effort, consisting of renowned scientists from around the globe. These results, descri…
Show more

 Helix Frequently Asked Questions

  • When was Helix founded?

    Helix was founded in 2015.

  • Who are Helix key executives?

    Helix's key executives are James Lu, Marc Laurent and Kirsten Mouritsen.

  • How many employees does Helix have?

    Helix has 239 employees.

  • What is Helix revenue?

    Latest Helix annual revenue is $10 m.

  • What is Helix revenue per employee?

    Latest Helix revenue per employee is $41.8 k.

  • Who are Helix competitors?

    Competitors of Helix include 23andMe, MyHeritage and Orig3n.

  • Where is Helix headquarters?

    Helix headquarters is located at 101 S Ellsworth Ave, San Mateo.

  • Where are Helix offices?

    Helix has offices in San Mateo and San Diego.

  • How many offices does Helix have?

    Helix has 2 offices.